Harrow, Inc. (HROW): A Bull Case Theory

We came across a bullish thesis on Harrow, Inc. (HROW) on Simon’s Substack by Simon. In this article, we will summarize the bulls’ thesis on HROW. HROW Technologies, Inc.'s share was trading at $44.07 as of Sept 27th. HROW’s trailing P/E was 9.64 according to Yahoo Finance.

[caption id="attachment_1236667" align="aligncenter" width="768"] A pharmacist discussing with a patient wearing a face mask, examining their eye to diagnose a macular degeneration.[/caption]

Harrow (NASDAQ: HROW) is a U.S. pharmaceutical company that develops, produces and sells ophthalmic drugs. Its...